SYNAGISTICS (02562) plans to acquire a big data and digital transformation platform company with the goal of serving over 1,000 renowned enterprises.
Lion Rock Holdings (02562) announces that on January 23, 2025, the company entered into a non-binding agreement with a potential seller...
SYNAGISTICS (02562) announced that on January 23, 2025, the company entered into a non-binding investment letter of intent with a potential seller, proposing a potential acquisition of up to 100% of the target company's equity as stated in the investment letter of intent. The cost of the potential acquisition will be determined after further negotiations between the parties.
The potential target company is a limited company established in China, a Chinese big data and digital transformation platform company founded in 2011. The company has over 1000 corporate and brand clients in five major industry sectors, including some of China's largest state-owned enterprises and retail brands that use the potential target group's patented platform solutions to manage their business processes (including data management and analysis, e-commerce, ERP and CRM, all provided through a fully integrated SAAS model).
Related Articles

On October 14, Consun Pharma (01681) spent HK$4.8951 million to buy back 320,000 shares.

SIS INT'L (00529) will invest about 8.349 million Hong Kong dollars to acquire 50.01% stake in Gestetner and intends to make a mandatory tender offer to the remaining shareholders.

ALPHAMAB-B(09966) spent 3.9669 million Hong Kong dollars on October 14th to repurchase 293,000 shares.
On October 14, Consun Pharma (01681) spent HK$4.8951 million to buy back 320,000 shares.

SIS INT'L (00529) will invest about 8.349 million Hong Kong dollars to acquire 50.01% stake in Gestetner and intends to make a mandatory tender offer to the remaining shareholders.

ALPHAMAB-B(09966) spent 3.9669 million Hong Kong dollars on October 14th to repurchase 293,000 shares.

RECOMMEND